Macroaxis provides Theravance Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Theravance positions. The advice algorithm takes into account all of Theravance Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Theravance buy-and-hold prospective. Also please take a look at World Market Map.
(1.14), sortino ratio of (0.003951) and treynor ratio of 0.2237We provide advice to complement the current expert consensus on Theravance. Our dynamic recommendation engine harnesses multi - dimensional algorithm to analyze the corporation potential to grow using all technical and fundamental data available at the time. To make sure Theravance Inc is not overpriced, please validate all Theravance fundamentals including its Cash per Share, and the relationship between Price to Book and Number of Employees . Given that Theravance Inc has Number of Shares Shorted of 24.88 M, we advise you double-check Theravance Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Theravance Inc is 'Not Rated'. For the selected time horizon Theravance Inc has a risk adjusted performance of 0.0378, jensen alpha of 0.0225, total risk alpha of